India TodayHealth
Beyond Ozempic and Mounjaro, concern grows over peptides
As popular weight-loss drugs such as Ozempic and Mounjaro draw attention, concern is growing over unapproved peptides marketed for similar effects. These products may lack reliable evidence and clear safety standards because they have not undergone regulatory review.
This card is an AI-assisted summary of reporting published by India Today. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.